The product is available in that country directly through the company's website and through its Beyond Human marketing and sales platform.
Apeaz Arthritis Cream is a fast acting, FDA monograph pain relieving drug and over-the-counter medication cream formulated to soothe the pain in joints and muscles.
It also contains ingredients such as methyl-sulfonyl methane (MSM) and glucosamine sulfate known to help damaged cartilage for stronger and more pressure resistant joints.
Apeaz is indicated to relieve acute pain, arthritis pain, athletic injuries, muscle soreness, muscle stiffness, muscle and joint pain, simple backache, and strains and sprains.
Innovus Pharma is an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialisation, licensing, and development of safe and effective non-prescription medicine and consumer care products to improve men's and women's health and vitality and respiratory diseases.
AstraZeneca launches Phase III THARROS trial for BREZTRI in COPD to assess cardiopulmonary outcomes
Merck finalises acquisition of Harpoon Therapeutics Inc
Pfizer reveals strong efficacy data for ABRYSVO in older adults against RSV
Nuvalent's NVL-520 receives FDA breakthrough therapy designation
Dassault Systèmes enhances patient care with virtual twin experience at Paris hospital
Pulmonx initiates CONVERT II trial for AeriSeal System in COPD treatment
Priority Review of Dupixent underway by FDA for COPD treatment
AstraZeneca boosts vaccine portfolio with acquisition of Icosavax
AstraZeneca reports positive resultsfor Tagrisso in Stage III lung cancer trial
AstraZeneca announces US acceptance of BLA for datopotamab deruxtecan to treat lung cancer
Erasca agrees clinical trial deal with Novartis to study naporafenib in combination with trametinib
FDA accepts Bristol Myers Squibb's Augtyro application for Priority Review